Search research articles
Contact Us
Filters
Showing results (131-140 of 236) with videos related to
Page
of 24
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2009
Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma
Patrick Veit-Haibach, Florian M Vogt, Robert Jablonka, et al.
European Radiology
|
August 17, 2010
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component
Patrick Veit-Haibach, Marc Schiesser, Jan Soyka, et al.
BMC Cancer
|
May 11, 2018
<sup>18</sup>FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study
Paul M Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 19, 2007
Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT
Florian M Vogt, Gerald Antoch, Patrick Veit, et al.
Magnetic Resonance in Medicine
|
February 3, 2015
Zero TE MR bone imaging in the head
Florian Wiesinger, Laura I Sacolick, Anne Menini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2020
EANM/SNMMI practice guideline for [<sup>18</sup>F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0
Judit A Adam, Annika Loft, Cyrus Chargari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 22, 2008
Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Jan D Soyka, Patrick Veit-Haibach, Klaus Strobel, et al.
Cancers
|
April 13, 2023
Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin's Lymphoma
Claudia Ortega, Yael Eshet, Anca Prica, et al.
Clinical Nuclear Medicine
|
December 22, 2025
Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis
Seyed Ali Mirshahvalad, Ahmed Alghamdi, Mohammadreza Chavoshi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 25, 2007
TNM staging with FDG-PET/CT in patients with primary head and neck cancer
Patrick Veit-Haibach, Christopher Luczak, Isabel Wanke, et al.
Page
of 24
Search research articles
Search
Showing results (131-140 of 236) with videos related to
Sort By:
Page
of 24
European Journal of Nuclear Medicine and Molecular Imaging
|
January 22, 2009
Diagnostic accuracy of contrast-enhanced FDG-PET/CT in primary staging of cutaneous malignant melanoma
Patrick Veit-Haibach, Florian M Vogt, Robert Jablonka, et al.
European Radiology
|
August 17, 2010
Clinical value of a combined multi-phase contrast enhanced DOPA-PET/CT in neuroendocrine tumours with emphasis on the diagnostic CT component
Patrick Veit-Haibach, Marc Schiesser, Jan Soyka, et al.
BMC Cancer
|
May 11, 2018
<sup>18</sup>FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study
Paul M Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 19, 2007
Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT
Florian M Vogt, Gerald Antoch, Patrick Veit, et al.
Magnetic Resonance in Medicine
|
February 3, 2015
Zero TE MR bone imaging in the head
Florian Wiesinger, Laura I Sacolick, Anne Menini, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
December 4, 2020
EANM/SNMMI practice guideline for [<sup>18</sup>F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0
Judit A Adam, Annika Loft, Cyrus Chargari, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 22, 2008
Staging pathways in recurrent colorectal carcinoma: is contrast-enhanced 18F-FDG PET/CT the diagnostic tool of choice?
Jan D Soyka, Patrick Veit-Haibach, Klaus Strobel, et al.
Cancers
|
April 13, 2023
Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin's Lymphoma
Claudia Ortega, Yael Eshet, Anca Prica, et al.
Clinical Nuclear Medicine
|
December 22, 2025
Prognostic Value of [ 18 F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis
Seyed Ali Mirshahvalad, Ahmed Alghamdi, Mohammadreza Chavoshi, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 25, 2007
TNM staging with FDG-PET/CT in patients with primary head and neck cancer
Patrick Veit-Haibach, Christopher Luczak, Isabel Wanke, et al.
Page
of 24